Home » Topics » BioWorld Asia

BioWorld Asia
RSS

LEO Buyout Gels for Peplin: $288M, Plus Phase III Loan

Sep. 9, 2009

By Jennifer Boggs

Kinaris Targeting Myosins with Allosteric Inhibitors

Sep. 9, 2009

By Cormac Sheridan

Senexis Passes Milestone and Triggers £2.9M for Clinic Pathway

Sep. 9, 2009

Would-be Biogen Buyer's Path Clear, Elan in Tysabri Trouble

Sep. 9, 2009

By Catherine Hollingsworth

Irish Pharma Entrepreneur Puts Wealth into Medical Research

Sep. 9, 2009

By Cormac Sheridan

Tioga Pauses for Japanese Deal Ahead of Asimadoline Phase III

Sep. 9, 2009

By Jennifer Boggs

Other News To Note

Sep. 9, 2009

Ark Testing Second-Generation Gene Therapy in Heart Ailment

Sep. 2, 2009

UK Losing Leading Stem Cell Scientist: Minger Joins GE Firm

Sep. 2, 2009

Other News To Note

Sep. 2, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...